Author:
Mousavi Azam-Sadat,Mazhari Marjan Moradi,Guilani Mitra Modares,Ghaemmaghami Fatemeh,Behtash Nadereh,Akhavan Setareh
Abstract
Abstract
Introduction
Prediction of optimal cytoreduction in patients with advanced epithelial ovarian caner preoperatively.
Methods
Patients with advanced epithelial ovarian cancer who underwent surgery for the first time from Jan. to June 2008 at gynecologic oncology ward of TUMS (Tehran University of Medical Sciences) were eligible for this study. The possibility of predicting primary optimal cytoreduction considering multiple variables was evaluated. Variables were peritoneal carcinomatosis, serum CA125, ascites, pleural effusion, physical status and imaging findings.
Univariate comparisons of patients underwent suboptimal cytoreduction carried out using Fisher's exact test for each of the potential predictors. The wilcoxon rank sum test was used to compare variables between patients with optimal versus suboptimal cytoreduction.
Results
41 patients met study inclusion criteria. Statistically significant association was noted between peritoneal carcinomatosis and suboptimal cytoreduction. There were no statistically significant differences between physical status, pleural effusion, imaging findings, serum CA125 and ascites of individuals with optimal cytoreduction compared to those with suboptimal cytoreduction.
Conclusions
Because of small populations in our study the results are not reproducible in alternate populations. Only the patient who is most unlikely to undergo optimal cytoreduction should be offered neoadjuvant chemotherapy, unless her medical condition renders her unsuitable for primary surgery.
Publisher
Springer Science and Business Media LLC
Reference25 articles.
1. Landis SH, Murray T, Bolden S, Wingo PA: Cancer statistics, 1999. CA Cancer J Clin. 1999, 49: 8-31. 10.3322/canjclin.49.1.8.
2. Scully RE, Young RH, Clement PB: Tumors of ovary, maldeveloped gonads, fallopian, tube, and broad ligament. Atlas of tumor pathology, fascicle 23 3rd series. 1998, Washington, DC: Armed Forces Institute of pathology, 1-168.
3. Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun MJ: Cancer statistics, 2003. CA Cancer J clin. 2003, 53: 5-26. 10.3322/canjclin.53.1.5.
4. Hoskins WJ, Bundy BN, Thigpen JT, Omura GA: The influence of cytoreductive surgery on recurrence-free interval and survival in small-volume stage3 epithelial ovarian cancer: a gynecologic oncology group study. Gynecol Oncol. 1992, 47: 159-66. 10.1016/0090-8258(92)90100-W.
5. Hoskins WJ, McGurie WP, Brady MF, Homseley HD, Creaseman WT, Berman M, Ball H, Berek JS: The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma. Am J Obstet Gynecol. 1994, 170: 974-80.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献